Effectiveness of Bendamustine in Relapse or Refractory Lymphoma Cases: A Report From Turkey-The Turkish Oncology Group (TOG) Study.

dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorPaydas, Semra
dc.contributor.authorOcal, Ramazan
dc.contributor.authorYildiz, Birol
dc.contributor.authorNayir, Erdinc
dc.contributor.authorDogan, Mutlu
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorSurmeli, Zeki
dc.contributor.authorBarista, Ibrahim
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.authorOzgur, Gokhan
dc.contributor.authorErturk, Ismail
dc.contributor.authorOzaydin, Sukru
dc.contributor.authorPetekkaya, Halil Ibrahim
dc.contributor.authorUskent, Necdet
dc.date.accessioned2023-05-25T09:30:10Z
dc.date.available2023-05-25T09:30:10Z
dc.date.issued2017
dc.identifier.issn0732-183Xen_US
dc.identifier.urihttp://hdl.handle.net/11727/9203
dc.identifier.volume35en_US
dc.identifier.wos000411932200057en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/JCO.2017.35.15_suppl.e19027en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEffectiveness of Bendamustine in Relapse or Refractory Lymphoma Cases: A Report From Turkey-The Turkish Oncology Group (TOG) Study.en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: